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Partial equilibrium approximations in Apoptosis
Ya-Jing Huang∗, Wen-An Yong†
Abstract
Apoptosis is one of the most basic biological processes. In apoptosis, tens of species are involved
in many biochemical reactions with times scales of widely differing orders of magnitude. By the
law of mass action, the process is mathematically described with a large and stiff system of ODEs
(ordinary differential equations). The goal of this work is to simplify such systems of ODEs with
the PEA (partial equilibrium approximation) method. In doing so, we propose a general framework
of the PEA method together with some conditions, under which the PEA method can be justified
rigorously. The main condition is the principle of detailed balance for fast reactions as a whole.
With the justified method as a tool, we made many attempts via numerical tests to simplify the
Fas-signaling pathway model due to Hua et al. (2005) and found that nine of reactions therein can
be well regarded as relatively fast. This paper reports our simplification of Hua at el.’s model with
the PEA method based on the fastness of the nine reactions, together with numerical results which
confirm the reliability of our simplified model.
Keywords: Partial equilibrium approximation, apoptosis, biochemical reactions, the principle of
detailed balance, sensitivity analysis
1 Introduction
Apoptosis is one of the most basic biological phenomena. It is a cellular suicide route that allows for
the selective removal of superfluous and potentially dangerous cells. This genetically controlled process
ensures normal embryonic development, tissue homeostasis and normal immune-system function in mul-
ticellular organisms. On the other hand, defects in apoptosis may cause serious diseases such as cancer,
autoimmunity, and neurodegeneration [1, 2, 3, 4]. For these reasons, understanding the mechanism of
apoptosis is of fundamental importance.
The apoptotic process involves tens of biological molecules (species), which react within tens of bio-
chemical reactions with time scales of widely differing orders of magnitude. When the law of mass action
[5] is employed, it is described mathematically by a simultaneous system of tens of ordinary differential
equations (ODEs). Such a large scale and stiff system of ODEs can hardly help us to understand the
mechanism of the apoptosis.
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The goal of this work is to derive mathematically reliable simplifications of the large apoptosis system
proposed by Hua et al. in [6] for human Jurkat T cells. Two widely used methods for simplifying chemical
kinetics are the Quasi Steady-State Approximation (QSSA) [7, 8], also called the Bodenstein method,
and Partial Equilibrium Approximation (PEA) [9, 10, 11]. The former assumes that the concentrations
of transient intermediate species reach steady states and thereby the rate equations for the intermediate
species are replaced with algebraic relations. On the other hand, the PEA simply takes the fast reactions
in equilibrium. In this manner, the stiffness is removed and some algebraic constraints are obtained.
For both methods, the algebraic relations can be used to reduce the number of the rate equations and
consequently the chemical kinetics is simplified. An unexpected benefit of such simplifications is that
less parameters are needed for the simplified models than for the original ones. This is good because the
parameters are often not reliably known (see [9]).
The QSSA, PEA and their combinations have been extensively used to simplify chemical kinetics
mechanisms for many years, with great success [12, 13, 14, 15, 16, 17, 18]. They were also used by Okazaki
et al. in [19] to simplify the large apoptosis system in [6] (see comments below). However, these methods
seem to lack a systematically mathematical justification. Recently, we pointed out that the PEA method
can be rigorously justified for reversible reactions obeying the principle of detailed balance [20, 21], by
using the singular perturbation theory of initial-value problems for ODEs [22]. Thus, our simplification
will base on this justified PEA method and therefore is reliable.
As commented in [23], Okazaki et al.’s simplification seems baseless. In fact, when applying the
QSSA method for the intermediate species Casp8∗2:Casp3, Okazaki et al. assumed that the concentration
sum of the intermediate species and Casp8∗2 (an activated initiator caspase) was conserved and obtained
the Michaelis-Menten equation for the product (see Appendix A of [19]). The latter is only true if the
activated initiator caspase does not participate in other reactions. However, this is not the case here
because the activated caspase is simultaneously, instead of consecutively, involved in other reactions.
Similar conservation assumptions were used for several steps. This is why we question the simplified
model in [19], although it is successful in some sense.
This paper is a continuation of our previous work [23]. In [23], we showed that two molecules (Smac
and XIAP) involved in the apoptotic process, neglected in [19], are not negligible in general. Then we
applied the justified PEA method to obtain a very preliminary simplified model by assuming only six
reversible reactions to be fast. In the present paper, we will use the PEA method to further simplify
the large apoptosis system [6]. To do this, we firstly verify the principle of detailed balance for more
fast reactions as a whole. Having such a verification, the singular perturbation theory of initial-value
problems for ODEs can be employed to derive our simplified models. Then we use numerical simulations
to compare the new models with the original one and Okazaki et al.’s simplified model from various
aspects, including accuracy, sensitivity and the M-D transition behavior [19]. Moreover, we introduce
a new quantity to evaluate our simplifications. All numerical results confirm the reliability of both our
simplified models and the PEA method.
Let us remark that, thanks to its reliability, the justified PEA could be used as a tool to determine
whether or not a reversible reaction is relatively fast. To this end, one could numerically compare the
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solution of partial equilibrium computation with that of the fully non-equilibrium computation. If the
two solutions are close to each other, the reaction can be claimed to be relatively fast.
The paper is organized as follows. In Section 2 we present a general framework of the PEA method,
together with some conditions under which the method can be justified rigorously. The apoptosis process
is introduced in Section 3. The PEA method is used in Section 4 to simplify the apoptosis system by
checking the principle of detailed balance for nine reversible reactions as a whole. Numerical simulations
are reported in Section 5. Finally, the main results of this paper are summarized in Section 5.
2 The PEA Method
In this section we first present a general framework of the PEA method, together with some conditions
under which the method can be justified rigorously. Then we take the simplest system for enzyme
inhibition as an example to show how to use our PEA method.
2.1 A general framework of the PEA method
Consider a system with N chemical species Ci(i = 1, 2, · · · , N) participating in M reactions
ap1C1 + a
p
2C2 + · · ·+ a
p
NCN
k+p
GGGGGGGBF GGGGGGG
k−p
bp1C1 + b
p
2C2 + · · ·+ b
p
NCN (2.1)
for p = 1, 2, · · · ,M . Here the non-negative integers api and b
p
i are the stoichiometric coefficients of the
ith-species in the pth-reaction, and k+p and k−p are the respective forward and backward rate constants
of the pth-reaction. The reversibility means that both k+p and k−p are positive.
Denote by ui = [Ci](t) the concentration of the i
th-species C1 at time t. According to the law of
mass action [5], the evolution equation for ui is
dui
dt
=
M∑
p=1
(bpi − a
p
i )vp (2.2)
with
vp = k+pu
a
p
1
1 u
a
p
2
2 · · ·u
a
p
N
N − k−pu
b
p
1
1 u
b
p
2
2 · · ·u
b
p
N
N
being the reaction rate of the p-th reaction.
Suppose the firstM ′(≤M) reactions in (2.1) are much faster than others. Then the kinetic equations
in (2.2) can be rewritten in the vectorial form:
dV
dt
=
1
ε
Q1(V ) +Q2(V, Z),
dZ
dt
= Q3(V, Z).
(2.3)
Here V is an N ′-vector consisting of those ui so that the i
th-species participates in the fast reactions, Z
consists of the rest ui, ε is a small positive parameter characterizing the fastness, and Q1(V ), Q2(V, Z)
3
and Q3(V, Z) stand for the corresponding reaction rates. The introduction of ε is to make Q1(V ) have
the same order of magnitude as Q2(V, Z) and Q3(V, Z). A special case is that Z is void and V contains
all ui.
Assume that there is a steady state u∗ = (u∗1, u
∗
2, · · ·u
∗
N ) satisfying u
∗
i > 0 for all i and a zero net
flux condition for each fast reaction:
k+p(u
∗
1)
a
p
1 (u∗2)
a
p
2 · · · (u∗N )
a
p
N − k−p(u
∗
1)
b
p
1 (u∗2)
b
p
1 · · · (u∗N )
b
p
1 = 0, ∀p = 1, 2, · · · ,M ′.
This is just the principle of detailed balance [20] for the partial system consisting of the fast reactions
merely. Clearly, it can only be true when both k+p and k−p are positive, that is, reversible reactions.
Under this assumption, we know from [21] that there is a strictly convex function η = η(V ) so that
Q1(V ) can be written as
Q1(V ) = S(V )ηV (V )
for V with strictly positive components. Here S(V ) is a symmetric matrix with null-space independent
of V and ηV (V ) is the gradient of η(V ). Moreover, the singular perturbation theory [22] for initial-value
problems of ODEs can be applied to the stiff system in (2.3). In particular, the solutions to initial-value
problems of (2.3) converge uniformly to those of a corresponding reduced system, as ε goes to zero, in
any bounded time interval away from zero.
In order to derive the reduced system, we notice the V -independence of the null-space and denote
by Π the constant matrix whose rows span the left null-space of S(V ). Without loss of generality, we
assume that Π is of the form
Π = (Θ, I)
with I the unit matrix of proper order. Accordingly, we introduce the partition
V =

 X
Y

 , Q1(V ) =

 Qˆ1(X,Y )
Qˆ2(X,Y )

 , Q2(V, Z) =

 Q˜1(X,Y, Z)
Q˜2(X,Y, Z)

 .
This partition ensures that X can be uniquely and globally obtained by solving Qˆ1(X, Y˜ −ΘX) = 0 (see
[21] if necessary).
Define
Y˜ = Y +ΘX.
The kinetic equations in (2.3) can be rewritten as
dX
dt
=
1
ε
Qˆ1(X, Y˜ −ΘX) + Q˜1(X, Y˜ −ΘX,Z),
dY˜
dt
= Q˜2(X, Y˜ −ΘX,Z) + ΘQ˜1(X, Y˜ −ΘX,Z),
dZ
dt
= Q3(X, Y˜ −ΘX,Z).
(2.4)
4
As ε goes to zero, the reduced system for (2.4) is
Qˆ1(X, Y˜ −ΘX) = 0,
dY˜
dt
= Q˜2(X, Y˜ −ΘX,Z) + ΘQ˜1(X, Y˜ −ΘX,Z),
dZ
dt
= Q3(X, Y˜ −ΘX,Z).
(2.5)
From Qˆ1(X, Y˜ − ΘX) = 0 we solve X in terms of Y˜ , say X = Φ(Y˜ ). Substituting this expression into
the second and third equations in (2.5), we obtain


dY˜
dt
= Q˜2(Φ(Y˜ ), Y˜ −ΘΦ(Y˜ ), Z) + ΘQ˜1(Φ(Y˜ ), Y˜ −ΘΦ(Y˜ ), Z),
dZ
dt
= Q3(Φ(Y˜ ), Y˜ −ΘΦ(Y˜ ), Z).
This is our simplified model by using the PEA method. Note that the original variables X and Y are
recovered from
X = Φ(Y˜ ), Y = Y˜ −ΘΦ(Y˜ ).
In caseX can be solved from Qˆ1(X,Y ) = 0 in terms of Y , sayX = Ψ(Y ), we recall the fact thatX can
be obtained by solving Qˆ1(X, Y˜ −ΘX) = 0 and may well assume that both the Jacobian matrices Qˆ1X (of
Qˆ1(X,Y ) with respect to X) and [Qˆ1X−Qˆ1YΘ] are invertible. Then [I−Qˆ
−1
1XQˆ1YΘ] = Qˆ
−1
1X [Qˆ1X−Qˆ1YΘ]
is invertible. It is an easy exercise to show that the invertibility of [I − Qˆ−11XQˆ1YΘ] is equivalent to that
of [I − ΘQˆ−11XQˆ1Y ]. On the other hand, we deduce from Qˆ1(Ψ(Y ), Y ) = 0 that Qˆ1XΨ(Y )Y + Qˆ1Y = 0
and thereby Ψ(Y )Y = −Qˆ
−1
1XQˆ1Y . Now we compute from Y˜ = Y +ΘΨ(Y ) that
dY˜
dt
=
dY
dt
+ΘΨ(Y )Y
dY
dt
= [I −ΘQˆ−11XQˆ1Y ]
dY
dt
.
Thus we gain equations for Y :
dY
dt
= (I +ΘΨ(Y )Y )
−1(Q˜2(Ψ(Y ), Y, Z) + ΘQ˜1(Ψ(Y ), Y, Z)).
Consequently, the reduced system can be written as
dY
dt
= (I +ΘΨ(Y )−1Y )(Q˜2(Ψ(Y ), Y, Z) + ΘQ˜1(Ψ(Y ), Y, Z)),
dZ
dt
= Q3(Ψ(Y ), Y, Z)
(2.6)
together with the algebraic relation X = Ψ(Y ).
2.2 A simple example
In order to elucidate how to use the PEA method, we consider the simplest system for enzyme inhibition
[5]. This system is demonstrated graphically in Fig. 1 and reveals the competitively inhibitory mechanism,
where the enzyme reaction is stopped when the inhibitor is bound to the active site of the enzyme. In
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Figure 1: The simplest mechanism for enzyme inhibition
Fig. 1, the symbols E, S, I, P, C1 and C2 stand for the enzyme, the substrate, the inhibitor, the product
and two complexes, respectively. k1 and k−1 are the respective kinetic rate constants of the forward and
backward reaction for substrate binding, while k3 and k−3 are those of the inhibitor binding reaction. k2
is the rate constant of the substrate conversion reaction.
According to law of of mass action, the corresponding kinetic equations read as
d[C1]
dt
= v1 − v2
d[C2]
dt
= v3
d[E]
dt
= −v1 − v3 + v2
d[S]
dt
= −v1
d[I]
dt
= −v3
d[P ]
dt
= v2.
(2.7)
with
v1 = k1[E][S]− k−1[C1],
v2 = k2[C1],
v3 = k3[E][I]− k−3[C2].
Classically, the reactions for enzyme to bind to substrates and inhibitors are regarded as fast and
reversible. Thus we rewrite (2.7) as
d[C1]
dt
=
1
ε
vˆ1 − v2
d[C2]
dt
=
1
ε
vˆ3
d[E]
dt
= −
1
ε
vˆ1 −
1
ε
vˆ3 + v2
d[S]
dt
= −
1
ε
vˆ1
d[I]
dt
= −
1
ε
vˆ3
d[P ]
dt
= v2.
(2.8)
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where vˆ1 = εv1, vˆ3 = εv3, and vˆ1 and vˆ3 have the same order of magnitude as v2. Thanks to the
reversibility, it is obvious that there are positive numbers [E]∗, [S]∗, [C1]
∗, [I]∗ and [C2]
∗ such that
v1 = k1[E]
∗[S]∗ − k−1[C1]
∗ = 0, v3 = k3[E]
∗[I]∗ − k−3[C2]
∗ = 0.
Thus the PEA method above can be well applied to the stiff system (2.8).
The reduced system for (2.8) can be derived as follows. Set
X =
(
[C1], [C2]
)T
,
Y =
(
[E], [S], [I]
)T
,
Z = [P ].
the stiff system (2.8) can be rewritten as
dX
dt
=
1
ε

 vˆ1
vˆ3

+ v2

 −1
0

 ,
d(Y +ΘX)
dt
= v2


0
−1
0

 ,
d[P ]
dt
= v2
(2.9)
with
Θ =


1 1
1 0
0 1

 .
From vˆ1 = vˆ3 = 0, we get
[C1] = K1[E][S], [C2] = K3[E][I] (2.10)
with Kj = kj/k−j for j = 1, 3. Substituting these into the last two equations in (2.9), we obtain the
following ODEs
d([E] + [C1] + [C2])
dt
= 0,
d([S] + [C1])
dt
= −k2K1[E][S],
d([I] + [C2])
dt
= 0,
d[P ]
dt
= k2K1[E][S].
This, together with (2.10), is the simplified model by using the justified PEA method. This model can
be further simplified by using the conservation laws indicated in the first and third equations. We omit
it here and leave it to the interested reader.
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3 Apoptosis Systems
Here we introduce the large apoptosis system proposed by Hua et al. in [6] for human Jurkat T cells.
To begin with, we recall that there are at least two pathways to trigger apoptosis—intrinsic (mito-
chondrial) and extrinsic (death receptor) signalling pathways. Both induce death-associated proteolytic
and/or nucleolytic activities. The intrinsic pathway is initiated when the cell is severely damaged
or stressed, while the extrinsic one is activated when extracellular death ligands are bound by their
cognate membrane-associated death receptors such as TNF-R1(DR1,p55), Fas(DR2,CD95), DR3(APO-
3,TRAMP), DR4(APO-2,TRAIL-R1) and DR5(TRICK2,TRAOL-R2) [1, 24, 25, 26, 27].
The Fas-induced signaling pathway is among the best understood and can be schematically shown in
Fig. 2. It begins with the binding of Fas ligands (FasL), Fas and FADD (Fas-associated death domain)
to form the complex DISC (death-inducing signaling complex). The latter can recruits initiator caspases
such as caspase-8 (Casp8) molecules to cleave and activate them. The activated initiator caspase (Casp8∗2)
can cleaves and activates the executor caspase-3 (Casp3) to form Casp3∗ directly. The amount of Casp3∗
is the indicator of apoptosis. This way to activate Casp3 is called D-channel. In addition, Casp3 can
also be activated in a so-called M-channel. In this channel, Casp8∗2 cleaves Bid to generate truncated
(t)Bid. The tBid then binds to two molecules of Bax to form a complex tBid:Bax2, which will induce
the release of Cyto.c and Smac from the mitochondria. The released Cyto.c∗ will combine an adaptor
protein Apaf-1, ATP and caspase-9 to form apoptosome and thereby activate caspase-9. The activated
caspase-9 (Casp9∗) cleaves and activates Casp3. On the other hand, the M-channel can be blocked by
XIAP (X-linked inhibitor of apoptosis protein) and Bcl2 through their bindings to the released Smac*,
Casp9, Casp3*, Bax and tBid.
The Fas-signaling pathway model proposed by Hua et at. [6] consists of biochemical reactions (H1)–
(H25) given in Table 1. From this table we see that the process activating the initiator caspase-8 (Casp8)
consists of the reactions from (H1) to (H6), which is initiated by FasL. The activated Casp8∗2 enzymatically
cleaves caspase-3(Casp3) to produce activated executor Casp3∗ ((H7) and (H8)) and Bid to generate tBid
((H9) and (H10)) simultaneously. Then the tBid associates with two Bax to form tBid:Bax2 through
(H11) and (H12), which induces the release of Cyto.c and Smac from mitochondrial to cytosol ((H15)
and (H13)). The released Cyto.c (Cyto.c∗) combines Apaf (Apaf-1) and ATP to form an apoptosome
(Cyto.c∗:Apaf:ATP) in (H16), which recruits two caspase-9(Casp9) and generates the activated caspase-9
(Casp9∗) through (H17) to (H19). The activated Casp9∗ can also enzymatically cleaves and activates
caspase-3 ((H20) and (H21)). On the other hand, the roles of Casp9, Casp3∗, tBid and Bax can be
inhibited by binding to XIAP((H22) and (H23)) and Bcl2 ((H24) and (H25)), while the released Smac
(Smac*) can suppress the function of XIAP (H14). Table 1 also contains all the forward/backward rate
constants k±i(i = 1, 2, · · · , 25).
Observe that not every reaction in Table 1 is reversible and the reactions activating Casp8 are
independent of the rest. As in [19], we call the downstream process, consisting of reactions from (H7)
to (H25), as the intracellular-signaling subsystem (ISS). Moreover, we follow [19] and assume that the
concentration of ATP is a fixed constant. Thus, there are 28 species and 19 biochemical reactions involved
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Table 1: The Fas-signaling pathway model due to Hua et at. (2005)
Reaction ki k−i
(H1) FasL + Fas
kH1
GGGGGGGGGGGGGGGGGBFGGGGGGGGGGGGGGGGG
k
−H1
FasC 9.09 × 10−5nM−1s−1 1.00 × 10−4
(H2)a FasC : FADDp : Casp8q : FLIPr + FADD
kH2
GGGGGGGGGGGGGGGGGBFGGGGGGGGGGGGGGGGG
k
−H2
Fas : FADDp+1 : Casp8q : FILPr 5.00 × 10
−4nM−1s−1 0.2
(H3)b FasC : FADDp : Casp8q : FILPr + Casp8
kH3
GGGGGGGGGGGGGGGGGBFGGGGGGGGGGGGGGGGG
k
−H3
Fas : FADDp : Casp8q+1 : FILPr 3.50 × 10
−3nM−1s−1 0.018
(H4)b FasC : FADDp : Casp8q : FLIPr + FILP
kH4
GGGGGGGGGGGGGGGGGBFGGGGGGGGGGGGGGGGG
k
−H4
Fas : FADDp : Casp8q : FILPr+1 3.50 × 10
−3nM−1s−1 0.018
(H5)c FasC : FADDp : Casp8q : FLIPr
kH5
GGGGGGGGGGGGGGGGGA Casp8∗2 : p41 + FasC : FADDp : Casp8q−1 : FILPr 0.3s
−1
(H6) Casp8∗
2
: p41
kH6
GGGGGGGGGGGGGGGGGA Casp8∗
2
0.1s−1
(H7) Casp8∗
2
+ Casp3
kH7
GGGGGGGGGGGGGGGGGBFGGGGGGGGGGGGGGGGG
k
−H7
Casp8∗
2
: Casp3 1.00 × 10−4nM−1s−1 0.06
(H8) Casp8∗
2
: Casp3
kH8
GGGGGGGGGGGGGGGGGA Casp8∗
2
+ Casp3∗ 0.1s−1
(H9) Casp8∗
2
+ Bid
kH9
GGGGGGGGGGGGGGGGGBFGGGGGGGGGGGGGGGGG
k
−H9
Casp8∗
2
: Bid 5.00 × 10−4nM−1s−1 0.005
(H10) Casp8∗
2
: Bid
kH10
GGGGGGGGGGGGGGGGGGGA Casp8∗
2
+ tBid 0.1s−1
(H11) tBid + Bax
kH11
GGGGGGGGGGGGGGGGGGGBFGGGGGGGGGGGGGGGGGGG
k
−H11
tBid : Bax 2.00 × 10−4nM−1s−1 0.02
(H12) tBid : Bax + Bax
kH12
GGGGGGGGGGGGGGGGGGGBFGGGGGGGGGGGGGGGGGGG
k
−H12
tBid : Bax2 2.00 × 10
−4nM−1s−1 0.02
(H13) Smac + tBid : Bax2
kH13
GGGGGGGGGGGGGGGGGGGA Smac∗ + tBid : Bax2 1.00 × 10
−3nM−1s−1
(H14) Smac∗ + XIAP
kH14
GGGGGGGGGGGGGGGGGGGBFGGGGGGGGGGGGGGGGGGG
k
−H14
Smac∗ : XIAP 7.00 × 10−3nM−1s−1 2.21 × 10−3
(H15) Cyto.c + tBid : Bax2
kH15
GGGGGGGGGGGGGGGGGGGA Cyto.c∗ + tBid : Bax2 1.00 × 10
−3nM−1s−1
(H16) Cyto.c∗ + Apaf + ATP
kH16
GGGGGGGGGGGGGGGGGGGBFGGGGGGGGGGGGGGGGGGG
k
−H16
Cyto.c∗ : Apaf : ATP 2.78 × 10−7nM−1s−1 5.70 × 10−3
(H17) Cyto.c∗ : Apaf : ATP + Casp9
kH17
GGGGGGGGGGGGGGGGGGGBFGGGGGGGGGGGGGGGGGGG
k
−H17
Cyto.c∗ : Apaf : ATP : Casp9 2.84 × 10−4nM−1s−1 0.07493
(H18) Cyto.c∗ : Apaf : ATP : Casp9 + Casp9
kH18
GGGGGGGGGGGGGGGGGGGBFGGGGGGGGGGGGGGGGGGG
k
−H18
Cyto.c∗ : Apaf : ATP : Casp92 4.41 × 10
−4nM−1s−1 0.1
(H19) Cyto.c∗ : Apaf : ATP : Casp92
kH19
GGGGGGGGGGGGGGGGGGGA Cyto.c∗ : Apaf : ATP : Casp9 + Casp9∗ 0.7s−1
(H20) Casp9∗ + Casp3
kH20
GGGGGGGGGGGGGGGGGGGBFGGGGGGGGGGGGGGGGGGG
k
−H20
Casp9∗ : Casp3 1.96 × 10−5nM−1s−1 0.05707
(H21) Casp9∗ : Casp3
kH21
GGGGGGGGGGGGGGGGGGGA Casp9∗ + Casp3∗ 4.8s−1
(H22) Casp9 + XIAP
kH22
GGGGGGGGGGGGGGGGGGGBFGGGGGGGGGGGGGGGGGGG
k
−H22
Casp9 : XIAP 1.06 × 10−4nM−1s−1 1.00 × 10−3
(H23) Casp3∗ + XIAP
kH22
GGGGGGGGGGGGGGGGGGGBFGGGGGGGGGGGGGGGGGGG
k
−H22
Casp3∗ : XIAP 2.47 × 10−3nM−1s−1 2.40 × 10−3
(H24) Bcl2 + Bax
kH24
GGGGGGGGGGGGGGGGGGGBFGGGGGGGGGGGGGGGGGGG
k
−H24
Bcl2 : Bax 2.00 × 10
−4nM−1s−1 0.02
(H25) Bcl2 + tBid
kH25
GGGGGGGGGGGGGGGGGGGBFGGGGGGGGGGGGGGGGGGG
k
−H25
Bcl2 : tBid 2.00 × 10
−4nM−1s−1 0.02
The index (p, q, r) in reactions (a) takes values (0,0,0),(1,0,0),(1,0,1),(1,1,0),(2,0,0),(2,0,1),(2,0,2),(2,1,0),(2,1,1)
and (2,2,0). In reactions (b) it takes values (1,0,0),(2,0,0),(2,0,1),(2,1,0),(3,0,0),(3,0,1),(3,0,2),(3,1,0),(3,1,1) and
(3,2,0), while it takes values (2,2,0),(3,2,0),(3,2,1) and (3,3,0) in reactions (c).
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Figure 2: The Fas-induced apoptotic pathway, including two channels.
in the downstream process.
According to the law of mass action, the dynamics of the ISS is governed by 28 ordinary differential
equations
dU
dt
= Q(U). (3.1)
Here U = U(t) is a column vector with 28 components representing the concentrations of all the 28
species in the ISS:
U =
(
[Casp8∗2], [Casp8
∗
2 : Casp3], [Casp8
∗
2 : Bid], [Bid], [tBid], [tBid : Bax], [tBid : Bax2],
[Bcl2 : tBid], [Bax], [Bcl2 : Bax], [Bcl2], [Cyto.c], [Cyto.c
∗], [Cyto.c∗ : Apaf : ATP ],
[Cyto.c∗ : Apaf : ATP : Casp9], [Cyto.c∗ : Apaf : ATP : Casp92], [Apaf ], [Casp9
∗],
[Casp9], [Casp3], [Casp9∗ : Casp3], [Casp3∗], [Smac], [Smac∗], [XIAP ],
[Smac∗ : XIAP ], [Casp9 : XIAP ], [Casp3∗ : XIAP ]
)T
,
each element of the vector-valued function Q(U) of U is the change rate of concentration for the corre-
sponding species
Q(U) =
(
− v7 + v8 − v9 + v10 + v0, v7 − v8, v9 − v10,−v9, v10 − v11 − v25, v11 − v12, v12, v25,
−v11 − v12 − v24, v24,−v24 − v25,−v15, v15 − v16, v16 − v17, v17 − v18 + v19,
v18 − v19,−v16, v19 − v20 + v21,−v17 − v18 − v22,−v7 − v20, v20 − v21,
v8 + v21 − v23,−v13, v13 − v14,−v14 − v22 − v23, v14, v22, v23
)T
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Table 2: Non-zero initial concentrations of the species in the ISS model (Hua. et al. 2005)
Species Initial concentration(nM)
Casp3 200.00
Bid 25.00
Bcl2 75.00
Bax 83.33
Cyto.c 100.00
Smac 100.00
XIAP 30.00
Casp9 20.00
ATP 10000.00
Apaf 100.00
with vi(i = 7 · · · 25) the rate of the i-th reaction in Table 1:
v7 = k7[Casp8
∗
2
][Casp3]− k−7[Casp8
∗
2
: Casp3],
v8 = k8[Casp8
∗
2
: Casp3],
v9 = k9[Casp8
∗
2
][Bid]− k−9[Casp8
∗
2
: Bid],
v10 = k10[Casp8
∗
2
: Bid],
v11 = k11[tBid][Bax]− k−11[tBid : Bax],
v12 = k12[tBid : Bax][Bax]− k−12[tBid : Bax2],
v13 = k13[Smac][tBid : Bax2]
v14 = k14[Smac
∗][XIAP ]− k−14[Smac
∗ : XIAP ],
v15 = k15[Cyto.c][tBid : Bax2],
v16 = k16[Cyto.c
∗][Apaf ][ATP ]− k−16[Cyto.c
∗ : Apaf : ATP ],
v17 = k17[Cyto.c
∗ : Apaf : ATP ][Casp9]− k−17[Cyto.c
∗ : Apaf : ATP : Casp9],
v18 = k18[Cyto.c
∗ : Apaf : ATP : Casp9][Casp9]− k−18[Cyto.c
∗ : Apaf : ATP : Casp92],
v19 = k19[Cyto.c
∗ : Apaf : ATP : Casp92],
v20 = k20[Casp9
∗][Casp3]− k−20[Casp9
∗ : Casp3],
v21 = k21[Casp9
∗ : Casp3],
v22 = k22[Casp9][XIAP ]− k−22[Casp9 : XIAP ],
v23 = k23[Casp3
∗][XIAP ]− k−23[Casp3
∗ : XIAP ],
v24 = k24[Bcl2][Bax]− k−24[Bcl2 : Bax],
v25 = k25[Bcl2][tBid]− k−25[Bcl2 : tBid],
v0 is the constant rate of generation for Casp8
∗
2 from the upstream process and its value was suggested
in [19] as v0 = 0.001nMs
−1. In addition, the non-zero initial concentrations for U are taken as in [6, 19]
and are given in Table 2.
In [19], Okazaki et al. claimed that Smac and XIAP have little effect on the reaction process of the
ISS by studying the M-D transition behavior of both the ISS model and ISS(wo/S,X) (without Smac and
XIAP) model. So they did not consider reactions (H13), (H14), (H22) and (H23) in their simplification.
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However, in our previous paper [23] we found that Smac and XIAP should not be ignored because the
numerical results of these two models are quite different if initial concentrations are changed. Therefore,
our sequel discussion will base on the entire ISS system.
We conclude this section by explaining the M-D transition behavior. It means a D-channel and
M-channel switching behavior and the quantity of [Casp8∗2] is a control parameter. When a large amount
of Casp8∗2 is activated from the upstream process, it will directly induce cell death through the D-channel;
otherwise, the M-channel plays more important role for cell death. In [6], the authors claimed that the
effects of D-channel and M-channel can be altered by varying the amount of Casp8∗2 generated by DISC
[25, 26, 28], which is consistent with previous experiments.
4 Model reduction
In this section we use the PEA method to investigate the large apoptosis system (3.1). This system
contains 13 reversible reactions: (H7), (H9), (H11), (H12), (H14), (H16), (H17), (H18), (H20), (H22),
(H23), (H24) and (H25). In our preliminary work [23], we showed that the six reactions (H11), (H12),
(H16), (H17), (H24) and (H25) are fast. Because the PEA method has a solid mathematical basis, it
can be used as a tool to determine whether or not a reversible reaction is fast. After many attempts by
assuming some of the rest 7 reactions to be fast too, we find that the nine reversible reactions (H7), (H9),
(H11), (H12), (H16), (H17), (H18), (H24) and (H25) can be well regarded as fast.
Here we derive the corresponding simplified model under the assumption that the nine reversible
reactions are fast. According to the framework in Section 2, we decompose the concentration vector U as
U =


X
Y
Z

 .
Here X stands for the products of the nine reactions, Y for the reactants and Z for the rest:
X =
(
[Casp8∗2 : Casp3], [Casp8
∗
2 : Bid], [tBid : Bax], [tBid : Bax2],
[Bcl2 : Bax], [Bcl2 : tBid], [Cyto.c
∗ : Apaf : ATP ],
[Cyto.c∗ : Apaf : ATP : Casp9], [Cyto.c∗ : Apaf : ATP : Casp92]
)T
,
Y =
(
[Casp8∗2], [Bid], [tBid], [Bax], [Bcl2], [Cyto.c
∗], [Apaf ], [Casp9], [Casp3]
)T
,
Z =
(
[Cyto.c], [Casp9∗], [Casp9∗ : Casp3], [Casp3∗], [Smac], [Smac]∗, [XIAP ],
[Smac∗ : XIAP ], [Casp9 : XIAP ], [Casp3∗ : XIAP ]
)T
.
(4.1)
With this decomposition, the kinetic equations in (3.1) can be rewritten as
dX
dt
=
1
ε
Qˆ1(X,Y ) +Q1(X,Y, Z)
dY
dt
=
1
ε
Qˆ2(X,Y ) +Q2(X,Y, Z)
dZ
dt
= Q3(X,Y, Z).
. (4.2)
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Here the small parameter ε characterizes the fastness of the reversible reactions as in Section 2,
Qˆ1(X,Y ) = ε
(
v7, v9, v11 − v12, v12, v24, v25, v16 − v17, v17 − v18, v18
)T
,
Qˆ2(X,Y ) = ε
(
− v7 − v9,−v9,−v11 − v25,−v11 − v12 − v24,−v24 − v25,−v16,−v16,−v17 − v18,−v7
)T
,
stand for the change rates of concentration due to the rapid reactions, and
Q1(X,Y, Z) =
(
− v8,−v10, 0, 0, 0, 0, 0, v19,−v19
)T
,
Q2(X,Y, Z) =
(
v8 + v10 + v0, 0, v10, 0, 0, v15, 0,−v22,−v20
)T
,
Q3(X,Y, Z) =
(
− v15, v19 − v20 + v21, v20 − v21, v8 + v21 − v23,−v13, v13 − v14,−v14 − v22 − v23, v14, v22, v23
)T
,
are those for the other reactions. It is direct to check that
Qˆ2(X,Y ) + ΘQˆ1(X,Y ) ≡ 0 (4.3)
with Θ the following constant 9x9-matrix
Θ =


1 1 0 0 0 0 0 0 0
0 1 0 0 0 0 0 0 0
0 0 1 1 0 1 0 0 0
0 0 1 2 1 0 0 0 0
0 0 0 0 1 1 0 0 0
0 0 0 0 0 0 1 1 1
0 0 0 0 0 0 1 1 1
0 0 0 0 0 0 0 1 2
1 0 0 0 0 0 0 0 0


.
Recall that
v7 = k7[Casp8
∗
2
][Casp3]− k−7[Casp8
∗
2
: Casp3],
v9 = k9[Casp8
∗
2
][Bid]− k−9[Casp8
∗
2
: Bid],
v11 = k11[tBid][Bax]− k−11[tBid : Bax],
v12 = k12[tBid : Bax][Bax] − k−12[tBid : Bax2],
v16 = k16[Cyto.c
∗][Apaf ][ATP ]− k−16[Cyto.c
∗ : Apaf : ATP ],
v17 = k17[Cyto.c
∗ : Apaf : ATP ][Caps9]− k−17[Cyto.c
∗ : Apaf : ATP : Casp9],
v18 = k18[Cyto.c
∗ : Apaf : ATP : Casp9][Casp9]− k−18[Cyto.c
∗ : Apaf : ATP : Casp92],
v24 = k24[Bcl2][Bax]− k−24[Bcl2 : Bax],
v25 = k25[Bcl2][tBid]− k−25[Bcl2 : tBid].
(4.4)
Then for any given Y =
(
[Casp8∗2], [Bid], [tBid], [Bax], [Bcl2], [Cyto.c
∗], [Apaf ], [Casp9], [Casp3]
)T
with
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positive components, we use (4.3) to get
X =
(
[Casp8∗2 : Casp3], [Casp8
∗
2 : Bid], [tBid : Bax], [tBid : Bax2], [Bcl2 : Bax], [Bcl2 : tBid],
[Cyto.c∗ : Apaf : ATP ], [Cyto.c∗ : Apaf : ATP : Casp9], [Cyto.c∗ : Apaf : ATP : Casp92]
)T
with positive components such that v7 = v9 = v11 = v12 = v16 = v17 = v18 = v24 = v25 = 0. Thus, the
principle of detailed balance is verified.
After verifying the conditions for the PEA method to be reliable, we turn to write down the simplified
model. In view of (4.3), we define Y˜ = Y +ΘX. Then the ODEs in (4.2) become
dX
dt
=
1
ε
Qˆ1(X,Y ) +Q1(X,Y, Z),
dY˜
dt
= Q2(X,Y, Z) + ΘQ1(X,Y, Z),
dZ
dt
= Q3(X,Y, Z).
(4.5)
Guided by the framework in Section 2, we solve Qˆ1(X,Y ) = 0, namely,


v7 = k7[Casp8
∗
2
][Casp3]− k−7[Casp8
∗
2
: Casp3] = 0,
v9 = k9[Casp8
∗
2
][Bid]− k−9[Casp8
∗
2
: Bid] = 0,
v11 = k11[tBid][Bax]− k−11[tBid : Bax] = 0,
v12 = k12[tBid : Bax][Bax] − k−12[tBid : Bax2] = 0,
v16 = k16[Cyto.c
∗][Apaf ][ATP ]− k−16[Cyto.c
∗ : Apaf : ATP ] = 0,
v17 = k17[Cyto.c
∗ : Apaf : ATP ][Caps9]− k−17[Cyto.c
∗ : Apaf : ATP : Casp9] = 0,
v18 = k18[Cyto.c
∗ : Apaf : ATP : Casp9][Casp9]− k−18[Cyto.c
∗ : Apaf : ATP : Casp92] = 0,
v24 = k24[Bcl2][Bax]− k−24[Bcl2 : Bax] = 0,
v25 = k25[Bcl2][tBid]− k−25[Bcl2 : tBid] = 0.
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From these algebraic equations we can easily solve X in terms of Y :
[Casp8∗
2
: Casp3] =
k7[Casp8
∗
2
][Casp3]
k−7
= K7[Casp8
∗
2
][Casp3],
[Casp8∗
2
: Bid] =
k9[Casp8
∗
2
][Bid]
k−9
= K9[Casp8
∗
2
][Bid],
[tBid : Bax] = k11[tBid][Bax]
k−11
= K11[tBid][Bax],
[tBid : Bax2] =
k12[tBid:Bax][Bax]
k−12
= K12K11[tBid][Bax][Bax],
[Cyto.c∗ : Apaf : ATP ] = k16[Cyto.c
∗][Apaf ][ATP ]
k−16
= K16[Cyto.c
∗][Apaf ][ATP ],
[Cyto.c∗ : Apaf : ATP : Casp9] = k17[Cyto.c
∗:Apaf :ATP ][Casp9]
k−17
= K17K16[Cyto.c
∗][Apaf ][ATP ][Casp9],
[Cyto.c∗ : Apaf : ATP : Casp92] =
k18[Cyto.c
∗:Apaf :ATP :Casp9][Casp9]
k−18
= K18K17K16[Cyto.c
∗][Apaf ][ATP ][Casp9]2,
[Bcl2 : Bax] =
k24[Bcl2][Bax]
k−24
= K24[Bcl2][Bax],
[Bcl2 : tBid] =
k25[Bcl2][tBid]
k−25
= K25[Bcl2][tBid]
(4.6)
with Ki = ki/k−i for i = 7, 9, 11, 12, 16, 17, 18, 24, 25. Denote these relations by X = Ψ(Y ).
It is remarkable that the relations rely only on the 9 constants Ki, instead of the 18 constants k±i.
The latter are often not reliably known.
Substituting X = Ψ(Y ) into the second and third equations in (4.5), we obtain


dY˜
dt
= Q2(Ψ(Y ), Y, Z) + ΘQ1(Ψ(Y ), Y, Z),
dZ
dt
= Q3(Ψ(Y ), Y, Z)
and thereby gain equations for Y :
dY
dt
= (I +ΘΨ(Y )Y )
−1 dY˜
dt
= (I +ΘΨ(Y )Y )
−1(Q2(Ψ(Y ), Y, Z) + ΘQ1(Ψ(Y ), Y, Z)).
Consequently, the original system (3.1) of 28 ODEs can be approximated by the following 19 ODEs
dY
dt
= (I +ΘΨ(Y )Y )
−1(Q2(Φ(Y ), Y, Z) + ΘQ1(Ψ(Y ), Y, Z)),
dZ
dt
= Q3(Ψ(Y ), Y, Z)
(4.7)
together with nine algebraic relations
X = Ψ(Y )
being detailed in (4.6). Recall that Y and Z are defined in (4.1). We call this new simplified model as
ISS-2.
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Table 3: The ISS skeleton model due to Okazaki et al. (2008)
Reaction Rate constant
(S1) Casp8∗
2
+ Casp3GGGGGGGA Casp8∗
2
+ Casp3∗ 6.25.00 × 10−6nM−1s−1
(S2a) Casp8∗
2
+ BidGGGGGGGA Casp8∗
2
+ 0.0328tBid : Bax2 vS2a =
ka[Casp8
∗
2][Bid]
[Casp8∗
2
]+Ka
(ka = 0.1s
−1, Ka = 20nM)
(S2b) Cyto.c + tBid : Bax2GGGGGGGA 0.867Cyto.c
∗ : Apaf : ATP + tBid : Bax2 1 × 10
−3nM−1s−1
(S2c) Cyto.c∗ : Apaf : ATP + 2Casp9GGGGGGGA Cyto.c∗ : Apaf : ATP + Casp9 + Casp9∗ 1.46 × 10−6nM−1s−1
(S2d) Casp9∗ + Casp3GGGGGGGA Casp9∗ + Casp3∗ 1.96 × 10−5nM−1s−1
5 Numerical simulations
The purpose of this section is to show the reliability of our ISS-2 model by resorting to numerical
simulations. Precisely, we compare the ISS-2 model (4.6)–(4.7) with the entire ISS model (3.1) and
Okazaki et al.’s ISS skeleton model [19] in several aspects, including the accuracy, M-D transition behavior
and sensitivity. For the reader’s convenience, the skeleton model is given in Table 3. The simulations
were carried out with Matlab.
5.1 Accuracy of the ISS-2 model
We compute the concentration of each species as functions of time t for the entire ISS model, the ISS
skeleton model and our ISS-2 model, with initial concentrations from Table 2. Fig. 3(a) displays three
curves of Casp3∗ as functions of time t corresponding to the three models. In this figure, the equilibrium
value of Casp3∗—the indicator of apoptosis— of the ISS-2 model is almost the same as that of the ISS
model, whereas that of the skeleton model is slightly larger. The equilibrium values of all other species
for the ISS model and our ISS-2 model are also very close to each other. The curves of Casp3, Casp9∗ and
Bid as functions of time t are given in Fig. 3(b), Fig. 3(c), and Fig. 3(d), respectively. These numerical
results show that our ISS-2 model is a reliable simplification of the entire ISS model.
5.2 M-D transition behavior
The M-D transition behavior is explained at the end of Section 3. In [19], it was reported that initial
concentrations of Casp9 also have considerable impacts to the transition behavior. In order to study this
behavior, Okazaki et al. introduced two quantities γD and v
C
0 in [19]. The former was defined as the ratio
of the net production of Casp3∗ via the D-channel to its total production, while the latter represents the
critical value of v0 (the generation rate for Casp8
∗
2) corresponding to γD = 0.5. Note that, at γD = 0.5,
the effect of the M-channel is same as that of the D-channel.
As previously, we use the initial concentrations from Table 2 and numerically solve the three models
to obtain three curves of γD as a function of v0. The results are shown in Fig. 4(a). From this figure, we
see that the curve given by the ISS-2 model matches that by the ISS model quite well and is obviously
better than that by the skeleton model.
The curves of vC0 as a function of the initial concentration of Casp9 are shown in Fig. 4(b). From
this figure we see that when the initial concentrations of Casp9 are small, the values of vC0 for the three
models are almost the same. However, when the initial concentrations of Casp9 are large, the ISS skeleton
model behaves quite different from the ISS model. But our ISS-2 model still matches the ISS model very
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Figure 3: Comparison of the ISS model (red asterisk), the skeleton model (blue open circle) and our ISS-2
model (green dot). The initial concentrations are from Table 2. (a): the curves of Casp3∗ as functions of
t. (b): the curves of Casp3 as functions of t. (c): the curves of Casp9∗ as functions of t. (d): the curves
of Bid as functions of t.
17
10−4 10−2 100 102
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
ν0/nMs
−1
γ D
 
 
ISS
Skeleton
ISS−2
(a) M-D transition behaviors due to Casp8∗
2
10−1 100 101 102 103 104
10−8
10−6
10−4
10−2
100
102
104
[Casp9]0/nM
νC 0
/n
M
s−
1
 
 
ISS
Skeleton
ISS−2
(b) M-D transition behaviors due to Casp9
Figure 4: Comparison of the ISS model (red asterisk), the skeleton model (blue open circle) and the ISS-2
model (green dot) for the M-D transition behavior. (a): M-D transition behavior due to Casp8∗2. (b):
M-D transition behavior due to Casp9.
well. All these indicate that our ISS-2 model can well describe the actual M-D transition behavior and
are much better than the ISS skeleton model.
5.3 Sensitivity Analysis
Now we present some results on the sensitivity of our ISS-2 model. Because the half-time—the time for
Casp3∗ to attain half of its equilibrium value—is an important quantity to characterize how fast a cell
will die [6], we compute this quantity for the three models with initial data changed by one or two orders
of magnitude higher and lower than the baseline values given in Table 2. The numerical results are shown
in Fig. 5.
From Fig. 5 we see that, like the full apoptosis model due to Hua et al. [6], our ISS-2 model possesses
the symmetrical or asymmetrical properties of varying each species to the outcome. The result by the
ISS-2 model is very similar to that by the ISS model. A bit difference is that the half-time for the ISS-2
model is a little shorter than that for the ISS model, which is same as for the ISS skeleton model. This
is expected because the assumption of fast reactions slightly speeds up the whole apoptotic process.
To evaluate our simplified model, we follow our previous work [23] and introduce the quantity
αC3∗ =
equilibrium value of Casp3∗ for ISS-2
equilibrium value of Casp3∗ for ISS
to examine how different are the equilibrium values of Casp3∗ for the two models when changing initial
concentrations of a certain species. When initial concentrations of some species are changed, αC3∗ will
likely change too. For a good simplified model, such a quantity should be close to one.
We compute αC3∗ for changing initial concentrations of each species, including Casp3
∗, by one or
two orders of magnitude higher and lower than the baseline values as before. The result is given in Fig.
6. This result illustrates that αC3∗ is insensitive to most of initial concentration changes, except a little
sensitivity for Bcl2 and Bax. In conclusion, our ISS-2 model well retains the main features of the ISS
model and therefore can be viewed as a reliable simplification to the original ISS model.
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Figure 5: Sensitivity analysis of the ISS model, the skeleton model and the ISS-2 model. The overexpres-
sion or knockdown level of each species is changed one or two orders of magnitude of the baseline values
while the others are unchanged.
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Figure 6: The change of αC3∗ against initial concentrations. The overexpression or knockdown level
of each species is changed one or two orders of magnitude of the baseline values while the others are
unchanged.
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6 Summary
In this paper, we develop a general framework of the PEA method together with two conditions, under
which the method can be justified rigorously. These conditions are the fastness assumption and the
principle of detailed balance for fast reactions as a whole. Under these conditions, we simplify a general
system of chemical reactions governed by the law of mass action. This simplification clearly has a solid
mathematical basis.
Then we follow the general framework and study the ISS (intracellular–signaling subsystem) model
as the downstream process of the Fas-signaling pathway model proposed by Hua et al. (2005) for human
Jurkat T cells. Because the framework has a solid mathematical basis, it can be used as a tool to
determine whether or not a reaction is relatively fast. After many attempts via numerical tests, we found
that nine of reactions in the ISS model can be well regarded as fast.
Knowing that the nine reactions are faster than others, we use the justified PEA method and simplify
the ISS model to derive a so-called ISS-2 model. It is remarkable that the reversible reactions in apoptosis
obey the principle of detailed balance naturally. With numerical simulations, we compare the ISS-2 model
with the ISS model as well as Okazaki’s ISS skeleton model in several aspects, including the accuracy, M-
D transition behavior and sensitivity analysis. All the simulations show that the ISS-2 model is reliable.
In particular, the new model can very well capture the M-D transition behavior of the ISS model at large
initial concentrations of Casp9 and therefore improves Okazaki’s ISS skeleton model considerably (see
Fig. 4(b)).
At present, we are trying to simplify the upstream process with the justified PEA method. In the
future, we will also try to simplify the whole process by correctly combining the PEA method and the
QSSA method.
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